Skip to main content
. 2021 Nov 29;10(11):4023–4029. doi: 10.4103/jfmpc.jfmpc_851_21

Table 1.

Demography of study participants and symptomatology at the time of admission (n=154)

Variable Category Number of participants Percentage
Gender Male 57 37
Female 97 63
Age category <18 yrs 39 25.3
18 to 45 yrs 78 50.6
45 to 65 yrs 30 19.5
>65 yrs 7 4.5
Categorization based on physician assessed severity of symptoms A (no or mild) 109 70.8
B (moderate) 43 27.9
C (severe) 2 1.3
Comorbidities Present 15 9.7
Absent 139 90.3
Co-existing disease Hypertension 7 4.5
Cardiac disease 3 1.9
Diabetes Mellitus 2 1.2
Respiratory diseases 2 1.2
Dyslipidemia 1 0.6
Symptoms at the time of admission to CFLTC Present 120 77.9
Absent 34 22.1
Symptoms at the time of admission to CFLTC Cough 29 18.8
Fever 26 16.8
Headache 25 16.2
Rhinitis 23 14.9
Sore throat 18 11.7
Myalgia 13 8.4
Breathlessness 11 7.1
Fatigue 5 3.2
Chest pain 3 1.9
Diarrhea 3 1.9
Abdominal pain 2 1.3
Nausea 1 0.6
Skin rash 1 0.6
Medications during stay at CFLTC (Antibiotics) Taken 27 17.5
Not taken 127 82.5